Geron Announces Presentations at American Society of Hematology Annual Meeting
November 05, 2015 09:03 ET
|
Geron Corporation
MENLO PARK, Calif., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that three abstracts describing clinical and non-clinical data on imetelstat have been...
Geron Announces Conference Call to Discuss Third Quarter 2015 Financial Results
October 29, 2015 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the third quarter ended September 30, 2015, on Thursday, November 5,...
Geron to Present at the BIO Investor Forum
October 13, 2015 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Announces Initiation of Janssen Phase 2 Clinical Trial of Imetelstat in Myelofibrosis
September 16, 2015 07:30 ET
|
Geron Corporation
MENLO PARK, Calif., Sept. 16, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the dosing of the first patient in a Phase 2 clinical trial to evaluate imetelstat in...
Dual Publications in the New England Journal of Medicine Highlight Transformative Potential of Imetelstat in Hematologic Myeloid Malignancies
September 02, 2015 17:01 ET
|
Geron Corporation
MENLO PARK, Calif., Sept. 02, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced the publication of two papers in The New England Journal of Medicine (NEJM) in which the...
Geron Corporation Reports Second Quarter 2015 Financial Results
August 05, 2015 16:05 ET
|
Geron Corporation
MENLO PARK, Calif., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the second quarter ended June 30, 2015. Second Quarter 2015 Results For...